Picture of Valerio Therapeutics SA logo

ALVIO — Valerio Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Onxeo To Present Next-Generation PARP Inhibitor At European ESMO-TAT Congress 2020

Feb 27 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO TO PRESENT NEXT-GENERATION PARP INHIBITOR, OX401, AT
THE
EUROPEAN ESMO-TAT CONGRESS 2020

Source text for Eikon:  ID:nBw2DhkKBa 
Further company coverage:  C4X.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Valerio Therapeutics SA

See all news